News Search Results for "arthritis treatment"

All Sources  1 - 10 of about 20
All Sources  1 - 10 of about 20
1|2 Next >
ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatm...
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically ta...
PR Newswire via Yahoo! Finance, Wed Dec 16 05:30:00 PST 2009 Yahoo! News
ChemoCentryx Initiates Phase 2 Clinical Trial of CCX354 for the Treatm...
MOUNTAIN VIEW, Calif., Dec. 16 /PRNewswire/ -- ChemoCentryx, Inc.
redOrbit, Wed Dec 16 08:10:02 PST 2009 Yahoo! News
NICE seeks more data on Roche arthritis drug
Britain's cost-effectiveness watchdog said it was minded not to recommend Roche's new arthritis drug RoActemra on the state health service, but could change its mind if the drugmaker handed...
Reuters via Yahoo! UK & Ireland News, Tue Dec 15 19:51:00 PST 2009 Yahoo! News
Teenager with arthritis advocates for others
Being diagnosed with juvenile rheumatoid arthritis at the age of 14 hasn
The Beach Reporter, Tue Dec 15 22:41:13 PST 2009 Yahoo! News
(AFX UK Focus) 2009-12-16 00:16 UK's NICE seeks more data on Roche art...
LONDON, Dec 16 (Reuters) - Britain's cost-effectiveness watchdog said it was minded not to recommend Roche's new arthritis drug RoActemra on the state health service, but could change its m...
Interactive Investor, Tue Dec 15 16:26:30 PST 2009 Yahoo! News
Roche Should Give More Data on RoActemra Drug, U.K.
Dec. 16 (Bloomberg) -- A U.K. health-cost panel asked Roche Holding AG for more information about the drugmaker
Bloomberg, Wed Dec 16 00:51:13 PST 2009 Yahoo! News
BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results fo...
BioSpecifics Technologies Corp. , a biopharmaceutical company developing first in class collagenase-based products, today announced top-line efficacy and safety results from a Phase 2b clin...
PR Newswire via Yahoo! Finance, Wed Dec 16 06:40:00 PST 2009 Yahoo! News
Nitric oxide opens up new treatment option for septic shock
Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units.
News-Medical-Net, Tue Dec 15 23:27:06 PST 2009 Yahoo! News
Celgene's Psoriasis Treatment Performs Well In Midstage Study
Celgene Corp.'s (CELG) treatment for moderate-to-severe plaque-type psoriasis performed better than a placebo in a midstage clinical trial, suggesting it holds promise as an oral treatment.
Nasdaq, Tue Dec 15 05:32:00 PST 2009 Yahoo! News
Auxilium drug meets penile curvature study goal
Auxilium Pharmaceuticals Inc. said Wednesday its drug candidate Xiaflex met a key treatment goal in a midstage study focused on Peyronie's disease, or penile curvature.
AP via Yahoo! News, Wed Dec 16 07:54:04 PST 2009 Yahoo! News
1|2 Next >